Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 21 to 55

Cognitive training for anxiety, depression, and PTSD

Official title: Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol

Run by University of California, San Diego · NCT06273527 · Data updated 2026-11-12

This study is testing a brain training program to see if it can help people with anxiety, depression, or PTSD think more clearly and feel better.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages21 Years to 55 Years
SexAll
Enrollment128 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations1 site (San Diego, California)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedJune 1, 2027
Study endsAugust 1, 2027
Registry record updatedOctober 24, 2025
Trial IDNCT06273527 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21-55 with a diagnosis of mood, anxiety, or traumatic stress disorder and clinically elevated repetitive negative thinking.

Probably not a fit

Patients with severe substance use disorders, psychotic disorders, or those currently receiving psychosocial treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the cognitive and neural effects of a cognitive training intervention in individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participants will be randomly assigned to either a cognitive training program designed to enhance executive functioning or a control program believed to be less effective. The study will compare cognitive performance and brain responses during tasks before and after the intervention, focusing on the reduction of repetitive negative thinking symptoms. The ultimate goal is to develop effective cognitive training programs that can improve cognition and alleviate symptoms associated with these common psychiatric conditions.

Why it matters

Potential benefit: If successful, this intervention could significantly improve cognitive functioning and reduce symptoms in patients with anxiety, depression, and PTSD.

How similar studies have gone: While cognitive training interventions have been explored in various contexts, this specific approach targeting executive functioning in mood and anxiety disorders is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age 21-55
* fluent in English
* diagnosis of mood, anxiety, or traumatic stress disorder
* clinically elevated repetitive negative thinking
* outpatient status
* 6-week stability if taking selective serotonin reuptake inhibitor (SSRI) medications

Exclusion Criteria:

* past year diagnosis of severe alcohol or moderate or greater substance use disorder
* lifetime history of psychotic or bipolar I disorder
* acute suicidality necessitating immediate clinical intervention
* neurodegenerative or neurodevelopmental disorders
* history of moderate or severe traumatic brain injury or other known neurological condition
* sensory deficits that would preclude completing tasks
* conditions unsafe for completing MRI scanning (e.g., metal in body)
* current pregnancy
* currently receiving psychosocial treatment
* currently receiving psychiatric pharmacotherapy, except SSRIs

Where it's running

  • UC San Diego
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.